Hairy cell leukemia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
{{CMG}} {{AE}}{{HL}} | {{CMG}} {{AE}}{{HL}} | ||
{{SK}} Leukaemic reticuloendotheliosis; | {{SK}} Leukaemic reticuloendotheliosis; Reticuloendotheliosis leukemic; Histiocytic leukemia; Malignant reticulosis; Lymphoid myelofibrosis | ||
==[[Hairy cell leukemia overview|Overview]]== | ==[[Hairy cell leukemia overview|Overview]]== | ||
Revision as of 11:07, 21 October 2015
For patient information click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Synonyms and keywords: Leukaemic reticuloendotheliosis; Reticuloendotheliosis leukemic; Histiocytic leukemia; Malignant reticulosis; Lymphoid myelofibrosis
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hairy cell leukemia from other Diseases
Risk Factors
Epidemiology and Demographics
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Related chapters
External Links
de:Haarzellleukämie it:Tricoleucemia nl:Haarcelleukemie fi:Karvasoluleukemia sv:Hårcellsleukemi